Myricetin flavonoid significantly inhibited the interaction between IL-21 and IL-21R and suppressed JAK/STAT signalling and the downstream transcription factor Bcl-6, and reduced T follicular helper cell differentiation in Rheumatoid arthritis (RA), suggesting myricetin a therapeutic compound for RA. The gene discussed is BCL6; the disease is rheumatoid arthritis.